TABLE 1.
The therapeutic index of CPP-BoNTA proteins.
| Samples | IMLD50 (ng/kg) | Units (= ng) | IMED50 (ng/kg) | IMED50 (U/kg) | Therapeutic index IMLD50 (ng/kg)/IMED50 (ng/kg) |
|---|---|---|---|---|---|
| Botox | 3.41 | 0.068 | 0.12 | 1.77 | 28 |
| WT-BoNTA | 79.85 | 1.60 | 2.20 | 1.38 | 36 |
| TAT-BoNTA | 26.48 | 0.53 | 0.22 | 0.42 | 120 |
| Pep1-BoNTA | 34.89 | 0.70 | 0.37 | 0.53 | 94 |
| ZFP3-BoNTA | 98.97 | 1.98 | 0.70 | 0.35 | 142 |
| BoNTA- ZFP3 | 168.61 | 3.37 | 0.89 | 0.26 | 189 |
| ZFP3-BoNTA -ZFP3 | 780.89 | 15.62 | 2.77 | 0.18 | 282 |
Note: In the present study, the active unit (U) of Botox is re-defined as described in the Materials and Methods. One unit of BoNTA, sample is defined as the amount of proteins that, when intramuscularly injected into each mouse, result in 50% death.